Market Closed -
Other stock markets
|
Pre-market 07:38:35 | |||
8.63 USD | +6.28% | 8.585 | -0.52% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.91% | 5.97B | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.68% | 21.93B | |
-12.15% | 22.34B | |
-5.61% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Piper Sandler Downgrades ImmunityBio to Neutral From Overweight, Cuts Price Target to $4 From $10